Publications by members of the Mectizan Expert Committee in 2025

These are some journal articles published on topics relating to onchocerciasis and lymphatic filariasis by members of the Mectizan Expert Committee/Albendazole Coordination in 2025.

(Click the article’s title for details.)

Dr. Yaya I. Coulibaly

Towards elimination of Neglected Tropical Diseases: Strengthening partnerships, fostering collaboration, and promoting country ownership.

Xenomonitoring as an epidemiological tool supporting post-stop surveillance of albendazole-ivermectin mass drug distribution in the Bougouni-Yanfolila evaluation unit, Sikasso, Mali, in 2023.

Implementation of basic package of care improved socio-economic conditions of lymphedema patients in rural Mali after two years follow-up.

Exploring the impact of mobile and migrant populations on mass drug administration coverage and effectiveness in Africa: A scoping review protocol.

Dr. Alison Krentel

Opportunities and barriers arising from the COVID-19 pandemic for health campaign integration across immunizations, neglected tropical diseases, insecticide-treated bed nets, and vitamin A supplementation: A qualitative key informant interview study

Exploring the impact of mobile and migrant populations on mass drug administration coverage and effectiveness in Africa: A scoping review protocol.

Dr. Sébastien Pion
Association between Loa loa microfilaremia and anatomical hyposplenia in a rural area of the Republic of Congo: a population-based cross-sectional study

Chronic kidney disease related to Loa loa microfilaremia in a rural area of the Republic of Congo: a population-based cross-sectional study

Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: A population-based cross-sectional study (the MorLo project)

Female Loa loa worm polyinfection in human hosts

Incidence of loiasis clinical manifestations in a rural area of the Republic of Congo: Results from a longitudinal prospective study (the MorLo project)

Inflammation and hemostasis in loiasis before and after ivermectin treatment: A biological pilot cross-sectional study

Reasons for consultations and afflicted body systems in rural areas of The Republic of the Congo: A cross-sectional study

Reference values for cardiac dimensions and function in a rural population living in a loiasis-endemic area of the Republic of the Congo: An echocardiographic study

Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment

Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial

Dr. Thomas Nutman

Wb5, a novel biomarker for monitoring efficacy and success of mass drug administration programs for Wuchereria bancrofti elimination.

Xenomonitoring as an epidemiological tool supporting post-stop surveillance of albendazole-ivermectin mass drug distribution in the Bougouni-Yanfolila evaluation unit, Sikasso, Mali, in 2023.

Circulating Cell-Free Nucleic Acid Detection for Wuchereria bancrofti Infections.

Implementation of basic package of care improved socio-economic conditions of lymphedema patients in rural Mali after two years follow-up.

Improved Nucleic Acid Amplification Test for the Diagnosis of Onchocerciasis and Its Use for Detection of Circulating Cell-free DNA.

Prof. B.E.B. Nwoke

Crowdsourced surveillance for neglected tropical diseases, Nigeria

Dr. Kapa D. Ramaiah

Managing Lymphedema Induced by Lymphatic Filariasis: Implementing and Improving Care at the Individual and Programmatic Levels